Made in Italy intelligent therapy against rare lung cancer and other solid neoplasms

Made in Italy intelligent therapy against rare lung cancer and other solid neoplasms

Spread the love

Made in Italy intelligent therapy against rare lung cancer and other solid neoplasms

Entrectinib, Roche’s drug developed by a team of Italian researchers, has received Aifa’s approval as a molecularly targeted drug and as an agnostic therapy, which acts on the genetic alteration driver, regardless of the organ affected by the tumor

!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘415374439673532’);
fbq(‘track’, ‘PageView’);